NextGen Omics & Spatial Biology US 2025 (White)

March 27 - 28, 2025 | Boston, MA

From Novel Technologies to Clinical Applications:
Driving the Next Generation of Multi-Omics Research  

Overview NGS, Clinical Omics & Diagnostics Single Cell Analysis Spatial Multi-Omics

Explore NextGen Omics & Spatial Biology US 2025: Advancing Therapeutic Innovation Through Multi-Omics Research 

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics.

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

NGS, Clinical Omics & Diagnostics

Expand the applications of next-generation sequencing in your clinical & diagnostic workflows through Next Generation Sequencing & Clinical Diagnostics, highlighting the most need-to-know innovations in diagnostics, clinical genomics & bioinformatic technologies. Industry leading speakers will showcase effective strategies for integrating NGS techniques within drug development, with further discussion on standardizing bioinformatics, optimizing NGS-based assays and utilizing multi-omic data.

  • Over 600 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
  • Over 50 presentations focussed on the critical issues in NGS implementation and data integration
  • Take a deep dive into data harmonisation, integration and analysis. Presentations will include tools for analysing high-throughput sequencing data, large-scale multi-omics data analysis and AI/ML toolkits for multi-omics datasets
  • Discuss digital PCR & liquid biopsies. Hear from key opinion leaders’ in-depth presentations on PCR machines for NGS library preparation, developing nextgen MRD assays and advances in analysing cell-free DNA & CTCs  

Agenda at a Glance


  • Day One | Track 1: Advanced Sequencing Technologies
  • Day One | Track 2: Multi Omics Data Harmonization, Integration & Analysis
  • Day One | Track 3: Digital PCR & Liquid Biopsies
  • Day Two | Track 1: Novel Diagnostics For Infectious & Non-Infectious Disease
  • Day Two | Track 2: Applying Multi-Omics in the Clinic

Single Cell Analysis

Recent advances in single cell analytical tools have enabled increasingly deep cellular analyses at the genomic, transcriptomic and proteomic level. Join Single Cell Analysis to learn how to integrate the most exciting new techniques within drug development, from identifying novel therapeutic targets through to understanding patient responses to specific therapies. In-depth case studies also showcase emerging spatial approaches, with discussion on how to optimize their use within R&D.

  • Over 450 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
  • Over 40 presentations focussed on the most innovative spatial and single cell technologies, and their applications within diagnostics, clinical research and drug discovery
  • Advance your understanding emerging single cell technologies from novel technologies for single cell imaging, through to one pot assays, benchmarking single cell technologies and updates from single cell multi-omics, applying omics in the clinic, bioinformatics for single cell analysis and clinical genomics updates

Agenda at a Glance


  • Day One | Track 4: Emerging Single Cell Technologies
  • Day Two | Track 3: Bioinformatics For Single Cell Analysis
  • Day Two | Track 4: Applications Of Single Cell Technologies

Spatial Multi-Omics

Unlocking the Potential of Spatial Technologies 

Spatial Multi Omics are transforming drug development, allowing researchers to more precisely understand biological systems than ever before. At Spatial US, experts from across leading academic institutions and biopharma organizations showcase the most transformative spatial tools and their applications in target identification, biomarker discovery, translational research & clinical design. From data analytics to successful therapeutic case studies, it equips you with the information you need to successfully adopt spatial technologies into your workflows. 

  • Hear from and meet with the key innovators in spatial multi-omics. 2024 attendees included: Distinguished University Professor, George Mason University; Senior Scientist, AbbVie; Principal Scientist, Boehringer Ingelheim
  • New to 2025! Gain invaluable insights into novel multi-omics technologies for spatial genomics & transcriptomics. Presentations will include translating spatial imaging techniques & approaches into drug development multi-modality processing and spatial transcriptomic databases
  • New to 2025! Discuss spatial biology for oncology, immunology and neuroscience. Hear from expert speakers discussing the tumour environment, distribution of immune cells within the tumour and mapping cellular diversity in the brain  
  • New to 2025! Advance your understanding on novel multi-omics technologies for spatial proteomics & metabolomics: from developing novel technologies for protein analysis through to automated multi-omics workflows, spatial distribution of proteins within cell and distribution of metabolites at spatial resolution
  • Join a series of workshops, panel discussions & roundtables. Discussion sessions will include: ‘Overcoming the Challenges of Spatial Data Analysis’

Agenda at a Glance


  • Day One | Track 5: Novel Multi-Omic Technologies: Spatial Genomics & Transcriptomics
  • Day One | Track 6: Spatial Biology for Therapeutic Discovery & Development
  • Day Two | Track 5: Novel Multi-Omic Technologies: Spatial Proteomics & Metabolomics
  • Day Two | Track 6: Spatial Biology for Therapeutic Discovery & Development

 

NextGen Biomed 2025

Advancing Therapeutic Innovation Through Multi-Omics Research  

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics. 

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

Hear from past attendees of last year's Biologics 2024 conference

Explore the NextGen Omics & Spatial Biology US 2025 Programme

Antibody Society

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society

What to Expect at NextGen Omics & Spatial Biology US 2025

Networking & knowledge-sharing is at the heart of what we do, with 62 hours of pre-arranged 1-2-1 meetings and over 11 hours of networking solutions don't miss the opportunity to connect with 1000 leaders from across pharma, biotech, regulatory and academia.

Engaging Thought Leadership
Experience a variety of interactive discussions, thought leadership debated, & collaborative roundtables, with insights from industry leaders on key developments and pain points in the advancement of multi-omics.

Global Technology Showcase
An international exhibition showcasing cutting-edge technologies & services from premier providers in the scientific field.

Networking Emphasis
Unparalleled networking opportunities, including personalised 1-2-1 meetings, a vibrant drinks reception, and informal gatherings to foster meaningful connections.

NextGen Biomed - What to Expect Presenting 3
NextGen Biomed - What to Expect Exhibiting 5
NextGen Biomed - What to Expect Networking 1
1000

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments

NextGen Omics & Spatial Biology US 2025 Programme Highlights

Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:

NGS, CLINICAL OMICS & DIAGNOSTICS 
Panel Discussion: Overcoming Multi-Omics Data Harmonisation & Analysis Challenges 

Moderator: Ruslan Sadreyev, Director of Bioinformatics & Assistant Professor, Massachusetts General Hospital 
Panellists: Aridaman Pandit, Senior Principal Research Scientist, Abbvie; Felix Francis, Sr. Manager, Data Management and Analytics Technology Lead, Takeda; Luca Pinello, Associate Professor of Pathology, Harvard Medical School 

NGS, CLINICAL OMICS & DIAGNOSTICS
Presentation: An Update On Global Genomics & Diagnostics Policy  

Presented by: Virginia Acha, AVP Global Regulatory Policy & Intelligence, MSD

SINGLE CELL 
Panel Discussion: Single Cell Multi-Omics Integration – From The Pharma Perspective 

Panellists: Tao Yang, Director of Computational Biology, Eli Lilly 

SPATIAL MULTI-OMICS
Roundtable Discussion: Safety Biomarkers in the age of Spatial Biology    

Moderator: Marina Bleck, Principal Scientist, Boehringer Ingelheim 

SPATIAL MULTI-OMICS 
Workshop: Spatial Genomics & Transcriptomics to Investigate Tumor Biology  Chronic Disease Immunotherapies?

Two presentations followed by a panel discussion with insights from Yasser Riazalhosseini, Associate Professor & Head of Cancer Genomics, McGill University 
Stephen Wong, Department Chair & Centre Director Houston Methodist Hospital, Professor at Cornell Medical College 

Who is Speaking at NextGen Omics & Spatial Biology US 2025?

Aleksandra Markovets
Director,
AstraZeneca
Alina Ainbinder
Principal Scientist,
Takeda
Angela Hadjipanayis
Global Director of High Content Data Generation,
Sanofi
Deidre Dalmas Wilk
Director,
GSK
Jasmine Plummer
Director,
St. Jude Children's Research Hospital
Jia-Ren Lin
Director,
LSP, Harvard Medical School
Mike Makrigiorgos
Professor and Director, Medical Physics and Biophysics,
Dana-Farber Cancer Institute
Pascaline Mary
Senior Director,
Hi-Fi Bio
Ruslan Sadreyev
Director of Bioinformatics,
Massachusetts General Hospital
Shoh Asano
Senior Principal Scientist,
Pfizer
Virginia Acha
Associate Vice President, Global Regulatory Policy, MRL,
MSD
Yuchun Guo
Associate Director, Computational Biology and Machine Learning,
CAMP4 Therapeutic
Alexandra Tsolias
Scientist II,
Voyager Therapeutics
Ali Herman
Investigator,
National Institutes of Health
Alice Wan
Senior Scientist,
Abbvie
Aridaman Pandit
Senior Principal Scientist,
AbbVie
Brian Cunningham
Professor,
University of Illinios
Colles Price
Principal Scientist,
Takeda
Dongdong Lin
Scientist,
EMD Serono
Elsa Molina
Director, Single-Cell & Spatial Omics,
Salk Institute
Eugean Jiwanmall
Senior Research Analyst - Medical Policy & Technology Evaluation,
Independence Blue Cross
Felix Francis
Senior Manager Data Management and Analytics,
Takeda
Gabor Balazsi
Professor,
Stony Brook University
Gang Wu
Director, Center for Applied Bioinformatics,
St Jude Children's Research Hospital
Giorgio Gaglia
Head of Systems Biology, Precision Medicine & Computational Biology,
Sanofi
Guolin Zhang
Principal Scientist,
Sensei Therapeutics
Jan Schejbal
Senior Scientist I,
AbbVie
Joann Arce
Assistant Professor of Paediatrics,
Harvard Medical School
Jun Wang
Associate Professor,
Stony Brook University
Kalina Hristova
Professor of Materials Science & Engineering Institute for NanoBioTechnology,
Johns Hopkins University
Keri Martinowich
Associate Professor and Lead Investigator,
Lieber Institute for Brain Development
Kieran Campbell
Assistant Professor & Research Group Lead,
University of Toronto & Lunenfeld-Tanenbaum Research Institute
Kimberly Smythe
Staff Scientist,
Fred Hutchinson Cancer Center
Leonora Balaj
Assistant Professor,
Massachusetts General Hospital
Lin Wu
Director, Genome Modification Facility,
Harvard University
Luca Pinello
Associate Professor,
Massachusetts General Hospital/Harvard Medical School
Marina Bleck
Principal Scientist,
Boehringer Ingelheim Pharmaceuticals, Inc.
Maxime Dhainaut
Director of Functional Genomics,
Noetik
Nikolai Slavov
Professor,
Northeastern University
Priya Chockalingam
Vice President, Head of Clinical Bioanalytics & Translational Sciences,
Beam Therapeutics
Priyank Patel
Senior Scientist,
Boehringer Ingelheim
Rajib Schubert
clinical development lead,
roche
Ricardo de Matos Simoes
Instructor,
DFCI
Sammy Ferri-Borgogno
Instructor,
MD Anderson Cancer Center
Shuqiang Li
Lead Scientist, Translational Immunogenomic Laboratory,
Dana-Farber Cancer Institute
Simona Cristea
Head of Data Science,
DFCI
Sourav Choudhury
Lab Head,
Sanofi
Tao Yang
Director of Computational Biology,
Eli Lilly
Theodore Perkins
Senior Scientist,
Ottawa Health Research Institute
Troy McEachron
Principal Investigator,
National Institutes of Health
Wardiya Afshar Saber
Research Fellow,
Boston Children's Hospital
Wenning Qin
Senior Vice President Innovation,
eGenesis
Winston Hide
Associate Professor,
Beth Israel Deaconess Medical Center / Harvard Medical School
Xiang Chen
Associate Member,
St Jude Children's Research Hospital
Yan Tang
Principal Investigator,
Brigham & Women’s Hospital
Yasser Riazalhosseini
Associate Professor,
McGill University
Young Don Kwak
Principal Scientist ll,
Novartis
Yu-Chi Chen
Scientist,
NCATS/National Institutes of Health
Yu-Hwa Lo
Professor,
University of California, San Diego
Zongmei Gao
Senior Scientist,
Abbvie

Interested in Sponsoring NextGen Omics & Spatial Biology US 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

2025 Sponsors Include

New Opportunities

The Start-up Zone

The start-up zone provides a unique opportunity to for you to exhibit, network, and pitch to our global audience of pharma, biotech, and investment professionals. 

It's designed for start-ups from across the biologics space, working on cutting-edge therapies, innovative platform technologies, products, and solutions and is an ideal platform to share your business plans. 

There are two options, based on the size of your organisation with prices starting from £1,500 (+VAT). 

For further information and to get started submit the application form below.

Criteria:

To qualify your company must be:

  • Therapeutic Start-Up, Emerging Technology OR Service Start-Up
  • Operating No More Than 5 Years
  • 0 – 30 employees
  • Pre-Series A Funding

 

Successful applications receive:

  • 1 Full Conference Pass
  • 10-Minute Presentation Opportunity
  • 1x1m Space in Start-Up Zone
  • Logo Featured on Event Website & App as a Participating Start-Up
  • Ability to Arrange Peer to Peer Meetings via the Congress App

2025 Young Scientist Awards (YSA) for Best Poster Presentation

The NextGen Biomed Young Scientist Awards include the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist.

Please submit your poster presentation by no later than 13th January 2025 in the below category:

  • Protein/Antibody Engineering
  • Bioanalysis & Characterisation
  • Next Generation Biotherapeutics
  • Peptides Chemistry & Therapeutics
  • Oligonucleotides Chemistry & Therapeutics
  • Sustainable Chemistry & Manufacturing
  • Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
  • Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13th January 2025
  • ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA

Applicants must follow the procedure as follows: 

  • Register and submit an abstract by 13th January 2025 using the registration link to the left on this page 
  • Once registered you will be provided with the online abstract submission form 
  • Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.) 
  • The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event 
  • The winners’ 10-minute oral presentations will take place during the networking drinks on day 2 

The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the NextGen Biomed series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.

The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights. 

ScipioBio

 

"The support from the Oxford Global team at NextGen Omics US 2024 was excellent - everyone went beyond to help us, it is rare to experience such support."


Chief Business Officer
Scipio Bio

b6fc1bbe-f2c7-48f4-ab7b-860f705182f9-2-5668375logo-logo-levitasbio-R-full-color-(1)

 

"Very professional and a high dedication to vendor needs and delivering on agreed upon packages. Christian is extremely attentive and customer driven, and this is also demonstrated by the Oxford Global team."

Senior Product Marketing Manager
Levitasbio

BD Logo-1

 

"NextGen Omics US was well organised, with highly relevant and enaged attendees."


Senior Sales Specalist, Single-Cell Multiomics
Business Development Manager – Northern Europe, Canopy Biosciences® – A Bruker Company

Exact Sciences Logo

"NextGen Omics US 2024 was a great networking opportunity, the meeting aspect of appointment setting was great. Everyone has been so helpful and responsive and ahead of our needs."


Regional Oncogenomic Liaison

Exact Sciences

Allumiqs

 

"NextGen Omics US 2024 was a great, we got good value out of it and are considering coming back to another event!"


Digital Marketing Manager

Allumiqs

Plan Your Visit

Sheraton Boston Hotel
39 Dalton Street, Boston, Massachusetts, USA, 02199

Directions

  • By AirBoston Logan International Airport – Sheraton Boston Hotel is 4 miles from the International Airport. A single taxi ride to the hotel will cost approx. $26-$35 and will take around 11 minutes. Additionally, you could get subway from Prudential- Government Center then to Airport.
  • By Bus - The closest bus stop to the venue is Boylston Street, which is a 5min walk away. If you’re wanting to get to South Station Train Terminal you will need to walk to Stuart St and dismount at Lincoln St, a short 2 minute walk you will find the station.
  • Parking – There is self-parking available (garage parking) at the hotel for $30 (this may be subject to state local taxes). There is no valet parking at this venue. For further information please contact the hotel directly.
  • Subway/Tram – The closest subway/tram stop to the venue is Prudential, which is a 3min walk away. If you’re wanting to get to South Station Train Terminal you will need to walk to Prudential get the E tram change over at Park Street on the Red line to South Station. 

More information on accommodation coming soon

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2025, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of NextGen Omics & Spatial Biology US 2025 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Interested in NextGen Omics & Spatial Biology US 2025?